Summary & Overview

HCPCS Q4227: Amniocore, per Square Centimeter (Add-On Supply)

HCPCS Level II code Q4227 bills for Amniocore supplied per square centimeter as an add-on item to a primary procedure. This code designates a biologic amniotic membrane product that is measured and billed by surface area; it is commonly used when amniotic membrane grafts are applied during surgical procedures or wound-care interventions. Nationally, add-on supply codes like Q4227 matter because they affect bundled payment considerations, clinical documentation requirements, and payer coverage determinations for biologic products.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and typical sites of service, a summary of which payers commonly address add-on biologic supplies, and where to look for coverage policy language. The publication also outlines common billing modifiers and administrative considerations associated with add-on supply codes and highlights areas where policy variation is frequent.

This report provides clinicians, billing staff, and policy analysts with benchmarks for how Q4227 is categorized, the clinical settings where it is used, and the payer landscape to consult for coverage and reimbursement rules. Data not available in the input is noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareQ4227HCPCS Level IIamniotic membraneamniocorewound careadd-on supplysurgical supplybiologic graftbilling

Billing Code Overview

HCPCS Level II code Q4227 represents Amniocore supplied per square centimeter as an add-on item, intended to be billed in addition to a primary procedure. The service involves providing a biologic amniotic membrane product measured and billed by surface area.

Service type: Biologic graft or wound-care product (amniotic membrane), supply

Typical site of service: Operative suite, outpatient surgical center, wound care clinic, or other clinical settings where a primary surgical or wound-management procedure is performed

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A typical patient is an adult with a chronic, non-healing wound (for example, a diabetic foot ulcer or a lower-extremity venous stasis ulcer) who has failed standard wound care measures including debridement, offloading, compression, infection control, and topical therapy. The wound care specialist (often a podiatrist, wound care physician, or plastic surgeon) evaluates the wound in an outpatient wound clinic or ambulatory surgical center. After wound bed preparation and debridement, the clinician applies an amniotic membrane product billed as Q4227 by surface area (per square centimeter) as an adjunctive biologic barrier to promote healing. The procedure may occur in an outpatient clinic, ambulatory surgical center, or hospital outpatient department depending on comorbidities, anticoagulation status, or need for concomitant procedures. Typical workflow: wound assessment and measurement, informed consent, local anesthesia as needed, surgical debridement and hemostasis, application and fixation of the amniotic membrane (documenting square centimeters used), dressing application, and post-procedure instructions with scheduled wound follow-up and documentation of units of Q4227 applied and any applicable modifiers (for example, for bilateral application, unusual procedural services, or reduced services).

Coding Specifications

Modifier	Description	When to Use
`00`	Default or no modifier specified (place-holder)	Rarely appended; use only if required by payer for systems that require a modifier field and no other modifier applies.
`22`	Increased procedural services	When work or resources substantially exceed typical requirements for application of the product (document justification in the record).
`23`	Unusual anesthesia	When medically necessary anesthesia is administered for a normally non-anesthetized procedure accompanying the application.
`52`	Reduced services	When less than the full service was performed but the product was still billed in a reduced manner with documentation.
`53`	Discontinued procedure	When the procedure was started but discontinued for patient safety; document reason and units applied if any.
`54`	Surgical care only	When another provider bills the postoperative care; use if billing only the intraoperative application.
`55`	Postoperative management only	When billing only the postoperative management surrounding the application.
`56`	Preoperative management only	When billing only preoperative care related to the application.
`62`	Two surgeons	When two surgeons of different specialties perform distinct portions of care during the same operative session involving the application.
`73`	Discontinued outpatient hospital/ambulatory procedure prior to anesthesia	When procedure halted before anesthesia administered; report if applicable to facility billing.
`78`	Return to the operating room for a related procedure during global period	When the patient returns to the OR for a related complication requiring repeat application or revision.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist services for Medicare Part B	When a qualified non-physician practitioner bills incident-to or independently under appropriate rules for product application services.
`QK`	Medical direction of two, three, or four certified registered nurse anesthetists (CRNAs)	If applicable when anesthesia care was medically directed during the procedure.
`QX`	CRNA service: medically necessary; CRNA personally performed service	If a CRNA provided anesthesia for the application and billing requires this distinction.

Taxonomy Code	Specialty	Notes
`174H00000X`	Wound Care Specialist (Podiatry)	Podiatrists commonly perform debridement and amniotic membrane application for lower-extremity wounds.
`207L00000X`	Plastic Surgery	Plastic surgeons perform advanced wound coverage and biologic graft placement in complex wounds.
`208000000X`	Family Medicine	Family physicians with wound-care focus may apply biologic products in outpatient clinics.
`363LF0000X`	Nurse Practitioner - Wound Care	Advanced practice clinicians often provide application and follow-up care in wound clinics.
`207P00000X`	General Surgery	General surgeons may apply adjunctive biologic products during wound procedures or soft-tissue reconstruction.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`E11.621`	Type 2 diabetes mellitus with foot ulcer	Diabetic foot ulcers are common indications for amniotic membrane adjunctive therapy to promote healing.
`L97.421`	Non-pressure chronic ulcer of left ankle with necrosis of muscle	Chronic lower-extremity ulcers with tissue loss often require debridement and biologic coverage.
`L97.322`	Non-pressure chronic ulcer of left calf with fat layer exposed	Deeper chronic ulcers may be treated with amniotic products after appropriate wound bed preparation.
`I83.013`	Varicose veins of right lower extremity with ulcer and inflammation	Venous stasis ulcers may receive biologic adjuncts in combination with compression therapy.
`L89.153`	Pressure ulcer of sacral region, stage 3	Select pressure ulcers with adequate preparation may be treated with advanced biologic dressings to aid healing.
`T81.4XXA`	Infection following a procedure, initial encounter	Post-procedural wound infection may modify use of biologic products and requires documentation if present.
`M86.9`	Osteomyelitis, unspecified	Underlying bone infection is a contraindication or modifier to application; must be assessed prior to `Q4227` use.
`R02`	Gangrene, not elsewhere classified	Severe ischemia or gangrene often precludes successful use of amniotic products until vascular status is addressed.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`11042`	Debridement, subcutaneous tissue (e.g., wound), first 20 sq cm or less	Often performed immediately before application of `Q4227` to prepare the wound bed.
`11043`	Debridement, muscle and/or fascia, first 20 sq cm or less	Used when deeper tissue debridement is required prior to amniotic membrane placement.
`97602`	Removal of devitalized tissue from wound(s), selective debridement, without anesthesia (e.g., wet-to-moist therapy)	May be billed for serial debridement sessions in outpatient wound care before definitive application of `Q4227`.
`15271`	Application of skin substitute graft to trunk, arms, legs; first 100 sq cm or less	Similar clinical use for biologic dressings; billed when a skin substitute application procedure is performed in conjunction with or instead of an amniotic product.
`29581`	Application of multi-layer compression system (for venous ulcer)	Adjunctive therapy often used after application of biologic products for venous stasis ulcers to promote healing.